# FDA recall D-1441-2019

> **Zydus Pharmaceuticals USA Inc** · Class II · drug recall initiated 2019-05-06.

## Product

Anastrozole Tablets, USP, 1 mg, 1,000-count bottle, Rx only,  Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India  Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534. NDC 68382-209-10

## Reason for recall

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-1441-2019
- **Recalling firm:** Zydus Pharmaceuticals USA Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-05-06
- **Report date:** 2019-06-26
- **Termination date:** 2021-09-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Pennington, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1441-2019

## Citation

> AI Analytics. FDA recall D-1441-2019. Retrieved 2026-07-10 from https://api.ai-analytics.org/recall/D-1441-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*